AAADV Slides HDillon 04.23.19

DEFINING AND MONITORING FOR SAES IN TRIALS OF I-O AGENTS Moderators: Elad Sharon; MD; National Cancer Institute Speakers Daniel Barber, PhD; National Institute of Allergy and Infectious Diseases Meredith Chuk, MD; U.S. Food and Drug Administration Nicole LeBoeuf, MD, MPH; Dana-Farber Cancer Institute Kelly Walkovich, MD; University of Michigan Blake Read more…

Walkovich A NICER Approach to IRAEs 050919

DEFINING AND MONITORING FOR SAES IN TRIALS OF I-O AGENTS Moderators: Elad Sharon; MD; National Cancer Institute Speakers Daniel Barber, PhD; National Institute of Allergy and Infectious Diseases Meredith Chuk, MD; U.S. Food and Drug Administration Nicole LeBoeuf, MD, MPH; Dana-Farber Cancer Institute Kelly Walkovich, MD; University of Michigan Blake Read more…

AAADV 2019 M.Chuk

DEFINING AND MONITORING FOR SAES IN TRIALS OF I-O AGENTS Moderators: Elad Sharon; MD; National Cancer Institute Speakers Daniel Barber, PhD; National Institute of Allergy and Infectious Diseases Meredith Chuk, MD; U.S. Food and Drug Administration Nicole LeBoeuf, MD, MPH; Dana-Farber Cancer Institute Kelly Walkovich, MD; University of Michigan Blake Read more…